New program to offer broad training in regenerative medicine including the integration of Medicine by Design's entrepreneurship and commercialization programs.
Partnership to accelerate health innovation commercialization in the Toronto life sciences ecosystem and in Canada
Community collaboration drove the new commitments in bold five-year plan
Themes like lessons learned from COVID-19, symbiotic partnerships and access to risk capital emerge in wide-ranging discussion.
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.
How do trainees get started on a path toward developing a product or starting a company? What steps do researchers need to take to move their regenerative medicine discoveries from the lab toward clinical impact? These are just some of the questions an expert panel tackled on July 30 at a virtual event titled Translating Research to Impact – Leveraging Our Ecosystem.
Weekly webinar series for trainees to cover key concepts in translation and commercialization of regenerative medicine.
How do you move innovative regenerative medicine discoveries out of the lab efficiently and effectively so [...]
The competition was the culmination of Medicine by Design’s “Pitching Science” workshop, a six-week long program for graduate students, post-doctoral fellows and research associates
Organizations collaborating to launch a health-themed cohort at CDL-Toronto to help technical teams take their health innovations to market by providing access to accomplished mentors and investors in life sciences.
"Toronto really is a unique place to pursue regenerative medicine research."
This month-long series of workshops, lab sessions, tours and conferences aims to advance knowledge and skills required to commercialize new therapies.
